Eastern Europe Is The Fastest-Growing Region For The Cancer Drugs MarketPosted by sainath on June 18th, 2018 Regions of the world that previously lagged in terms of cancer drug sales are now growing much faster than the established regions, a report from The Business Research Company shows. Fastest is Eastern Europe, where the market will grow at nearly 12% a year up to 2021, while Asia Pacific’s growth rate will be second fastest at 7.3% a year. This catch-up by these less economically developed regions will mean that the global market, worth 6 billion in 2017, will grow at 8.8 % a year up to 2021. In the established regions, North America, and Western Europe, which together accounted for nearly 80% of the market in 2017, growth is also expected to accelerate, to 6% and 6.8% respectively. Anti-cancer or anti-neoplastic agents are the drugs that prevent or inhibit or halt the proliferation and maturation of neoplasms, an abnormal growth of tissues commonly called tumors. These drugs prevent the growth of malignant tumors by affecting the process of cell division or by damaging the DNA and initiate apoptosis or by preventing the development and spread of neoplastic cells.
Where To Learn More Markets Covered: Blood Cancer; Breast Cancer; Cervical Cancer; Lung Cancer; Colorectal Cancer; Non-Small Cell Lung Cancer; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; Pancreatic Cancer; Skin Cancer; Ovarian Cancer; Bladder Cancer; Thyroid Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma) Companies Covered: F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc, Bayer AG, Takeda Pharmaceuticals Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil Time Series: Five years historic (2013-17) and forecast (2017-21). Data Segmentations: Global oncology drugs market historic and forecast size and growth rates for the world, 7 regions and 12 countries, Blood Cancer; Breast Cancer; Cervical Cancer; Lung Cancer; Colorectal Cancer; Non-Small Cell Lung Cancer ; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; segments historic and forecast size and growth rates for the world, 7 regions and 12 countries, Pancreatic Cancer; Skin Cancer; Ovarian Cancer; Bladder Cancer; Thyroid Cancer, for 12 countries, cerebrospinal fluid (csf) management segments size 2017 for 12 countries, global competitor sales and market shares. About The Business Research Company. The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information. The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Like it? Share it!More by this author |